PT1064943E - Combinacao possuindo actividade antilipemica, substancialmente isenta dos efeitos toxicos ou efeitos secundarios provocados pelos farmacos antilipemicos - Google Patents
Combinacao possuindo actividade antilipemica, substancialmente isenta dos efeitos toxicos ou efeitos secundarios provocados pelos farmacos antilipemicosInfo
- Publication number
- PT1064943E PT1064943E PT99830415T PT99830415T PT1064943E PT 1064943 E PT1064943 E PT 1064943E PT 99830415 T PT99830415 T PT 99830415T PT 99830415 T PT99830415 T PT 99830415T PT 1064943 E PT1064943 E PT 1064943E
- Authority
- PT
- Portugal
- Prior art keywords
- antilipemic
- pharmacies
- combination
- substantially free
- side effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99830415A EP1064943B1 (en) | 1999-06-30 | 1999-06-30 | Combination having antilipemic activity substantially free from toxic or side effects due to antilipemic drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1064943E true PT1064943E (pt) | 2005-06-30 |
Family
ID=8243483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99830415T PT1064943E (pt) | 1999-06-30 | 1999-06-30 | Combinacao possuindo actividade antilipemica, substancialmente isenta dos efeitos toxicos ou efeitos secundarios provocados pelos farmacos antilipemicos |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1064943B1 (pt) |
| AT (1) | ATE288751T1 (pt) |
| DE (1) | DE69923670T2 (pt) |
| DK (1) | DK1064943T3 (pt) |
| ES (1) | ES2237073T3 (pt) |
| PT (1) | PT1064943E (pt) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0667833B2 (ja) * | 1985-11-28 | 1994-08-31 | 雪印乳業株式会社 | 経腸栄養剤 |
| CA2007983C (en) * | 1989-01-18 | 1996-12-10 | Michael S. Brown | Coenzyme q10 with hmg-coa reductase inhibitors |
| IT1293067B1 (it) * | 1997-07-01 | 1999-02-11 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico |
-
1999
- 1999-06-30 EP EP99830415A patent/EP1064943B1/en not_active Expired - Lifetime
- 1999-06-30 PT PT99830415T patent/PT1064943E/pt unknown
- 1999-06-30 DE DE69923670T patent/DE69923670T2/de not_active Expired - Lifetime
- 1999-06-30 DK DK99830415T patent/DK1064943T3/da active
- 1999-06-30 AT AT99830415T patent/ATE288751T1/de active
- 1999-06-30 ES ES99830415T patent/ES2237073T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69923670T2 (de) | 2006-03-09 |
| ATE288751T1 (de) | 2005-02-15 |
| DK1064943T3 (da) | 2005-06-06 |
| EP1064943B1 (en) | 2005-02-09 |
| EP1064943A1 (en) | 2001-01-03 |
| DE69923670D1 (de) | 2005-03-17 |
| ES2237073T3 (es) | 2005-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105559A (en) | STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR | |
| BR9908690A (pt) | Composição farmacêutica contendo estatina e aspirina | |
| ATE263558T1 (de) | Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen | |
| IE970731A1 (en) | Product and method for the treatment of hyperlipidemia | |
| ATE288893T1 (de) | Polymorphe form von atorvastatin-calcium | |
| WO2006017698A3 (en) | Novel statin pharmaceutical compositions and related methods of treatment | |
| ATE422359T1 (de) | Verbindungen und pharmazeutische zusammensetzungen mit appetitunterdrückender aktivität | |
| BR9807234B1 (pt) | Composição farmacêutica compreendendo um composto tricílico e uma combinação de miristrato de isopropila e sebacato de dietila, com estabilidade e absorbilidade aumentadas e um pontencial de irritação reduzido | |
| BRPI0410049A (pt) | composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
| FI951856A0 (fi) | Farmaseuttinen koostumus osteoporoosin hoitamiseksi | |
| DE59608698D1 (de) | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure | |
| ATE417617T1 (de) | Mittel zur steurung der expression von il-12 | |
| WO2002011666A3 (en) | Derivatives of branched-chain lipophilic molecules and uses thereof | |
| BR9406747A (pt) | Uso de um composto compostos processos de preparação dos mesmos de inibição da ação de enzimas e de tratamento ou profilaxia de doença cardiovascular e formulação farmacêutica | |
| PT1064943E (pt) | Combinacao possuindo actividade antilipemica, substancialmente isenta dos efeitos toxicos ou efeitos secundarios provocados pelos farmacos antilipemicos | |
| CA2375378A1 (en) | Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines | |
| UY28729A1 (es) | Composiciones hipocolesterolemiantes | |
| RU2007148908A (ru) | Составы для снижения риска возникновения вызванной лекарственными средствами аритмии | |
| ATE231728T1 (de) | Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren | |
| BRPI0417747A (pt) | uso de compostos orgánicos | |
| CL2004001291A1 (es) | Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza. | |
| BG106918A (en) | Perocess for the preparation of sodium salts of statins | |
| TH78302A (th) | การรวมกันของสารประกอบอินทรีย์ | |
| TH52206A (th) | สารที่รวมเข้าด้วยกันของ สแททิน-คาร์บอกซิแอลคิลอีเธอร์ | |
| DE60018438D1 (de) | Pharmazeutische und/oder kosmetische zusammensetzungen |